Renaissance Capital logo

PIRS News

Pieris Pharmaceuticals prices IPO at $2.75

Pieris Pharmaceuticals, which is developing a therapy for iron deficiency in anemic patients with chronic kidney disease, raised $25 million by offering 9.1 million shares at $2.75, below yesterday's closing price of $3.26 on the OTC Market. Pieris Pharmaceuticals will begin trading on the NASDAQ today under the symbol PIRS. Oppenheimer & Co. and JMP Securities acted as lead...read more

Week ahead: Get ready for a dose of high-growth health care with 8 IPOs

TDOC

As many as 8 companies could go public in the US during the shortened holiday week. The week's three high-growth health care IPOs that are on the IPO calendar should receive the most interest, especially after ...read more

US IPO Weekly Recap: Year's hottest deal pops 186% in year's most active week with 13 IPOs

Things just got Seres in the IPO market. Thirteen companies went public this past week, more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its debut - the highest first-day pop since January 2014. The thirteen IPOs raised $1.9 billion, less than expected because 70%...read more

Week ahead: As many as 17 IPOs could price during the week of June 22

TRU

17 companies are on the calendar to go public this week and raise $2.5 billion. It should be the year's most active week in the IPO market; the second busiest week saw 10 IPOs in January. Investors have plenty of options this week, so expect IPO investors to demand discounts on some of the less hot...read more